CClinicalTrials.gg
RecruitingNCT06506201Updated Jul 18, 2025

Legs Dysmetria in Total Hip Replacement: Does Hip Approacches and Navigation Decrease the Risk?

An interventional study of Velys hip navigation and Standard of care in Hip Osteoarthritis, sponsored by Istituto Ortopedico Rizzoli. Recruiting at 1 site in Italy. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-07-18.

Sponsored by Istituto Ortopedico Rizzoli · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2024; still recruiting 2 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
136
Allocation
Randomized
Ages
50 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to collect clinical and radiological data from the case series of patients surgically treated with total hip arthroplasty at the Rizzoli Orthopaedic Institute.

The primary objective is to evaluate in terms of safety and efficacy the reduction of legs dysmetria and proper acetabular cup inclination intraoperatively when comparing anterior, direct lateral, and postero-lateral hip approaches conducted via traditional or navigation-assisted surgery.

The secondary objectives of the study are to evaluate, by comparing navigation-assisted and non-navigation-assisted hip approaches, intraoperatively the correct positioning of the prosthesis by analyzing the acetabular cup version; surgical timing; and number of intraoperative radiographs taken. In addition, the accuracy of preoperative planning will be assessed and a clinical evaluation performed during a follow-up of one year.

02

Conditions studied

  • Hip Osteoarthritis

Browse trials for

03

In context

Osteoarthritis, Hip

628 studies on the registry are indexed under Osteoarthritis, Hip; 121 are open to participants now.

This study's planned enrollment of 136 is above the median of 90 across 450 interventional studies indexed under Osteoarthritis, Hip.

Browse Osteoarthritis, Hip studies →

Lead sponsor

Istituto Ortopedico Rizzoli is the lead sponsor of 298 studies on the registry; 102 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age between 50 and 80 years;
  2. Signs and symptoms of hip osteoarthritis (pain intensity of at least 6 points of visual analogic scale pain - 0-10 scale in the previous week);
  3. Radiographic signs of hip osteoarthritis (Grade 3-4 according to Tonnis classification);

Exclusion criteria

Exclusion Criteria:

  1. Patients unable to express consent;
  2. Patients undergoing previous ipsilateral hip surgery;
  3. Patients undergoing lower limb surgery to be treated in the previous 12 months;
  4. Patients with malignant neoplasms;
  5. Patients with rheumatic diseases;
  6. Patients with uncontrolled diabetes;
  7. Patients with uncontrolled thyroid metabolic disorders;
  8. Patients abusing alcoholic beverages, drugs or medications;
  9. Body Mass Index > 35;
  10. Pregnant and/or fertile women.
  11. Pain intensity less than 6 points in accordance with the visual analogic scale scale.
  12. Patients with the presence of excessive deformity resulting from acetabular or femoral head dysplasia
  13. Patients who have already undergone total hip arthroplasty surgery on the affected hip.
  14. Previous extensive surgery of the reference joint (osteotomy around the hip, open or arthroscopic osteochondroplasty for femoral-acetabular conflict).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
136 participants (estimated)

Study arms

  • Experimental
    direct anterior approach with navigation assistance

    Patients treated surgically with total hip arthroplasty (direct anterior approach) with navigation assistance.

    Device: Velys hip navigation

  • Active comparator
    direct anterior approach without navigation assistance

    Patients treated surgically with total hip arthroplasty (direct anterior approach) without navigation assistance.

    Procedure: Standard of care

  • Experimental
    lateral direct approach with navigation assistance

    Patients treated surgically with total hip arthroplasty (lateral direct approach) with navigation assistance.

    Device: Velys hip navigation

  • Active comparator
    lateral direct approach without navigation assistance

    Patients treated surgically with total hip arthroplasty (lateral direct approach) without navigation assistance.

    Procedure: Standard of care

  • Experimental
    postero-lateral approach with navigation assistance

    Patients treated surgically with total hip arthroplasty (postero-lateral approach) with navigation assistance.

    Device: Velys hip navigation

  • Active comparator
    postero-lateral approach without navigation assistance

    Patients treated surgically with total hip arthroplasty (postero-lateral approach) without navigation assistance.

    Procedure: Standard of care

Interventions

  • DeviceVelys hip navigation

    Computer assisted surgery

  • ProcedureStandard of care

    surgery without navigation

06

What researchers measure

Primary outcomes

  1. Legs dysmetria in millimeters calculated in anteroposterior x-rays

    Legs lenght dysmetria in total hip replacement surgery

    Time frame: Intraoperatory

Secondary outcomes

  1. Cup orientation in grade° calculated in anteroposterior x-rays

    Cup orientation in total hip replacement surgery

    Time frame: Intraoperatory

07

Study locations

1 of 1 sites recruiting
  • Istituto Ortopedico Rizzoli
    Bologna, 40136, Italy
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06506201
Lead sponsor
Istituto Ortopedico Rizzoli
Responsible party
Sponsor
First posted
Jul 17, 2024
Start date
May 13, 2024
Primary completion
May 12, 2027 (estimated)
Completion
May 12, 2027 (estimated)
Last update
Jul 18, 2025

Study contacts

Federico Raggi, MD
Contact
federico.raggi@ior.it
051 6366122 ext. +39
Federico Raggi, MD
principal investigator · Isitituto Ortopedico Rizzoli

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion